PGNX : Analysis & Opinions

  1. Actavis' Q4 Earnings to Beat Expectations, Growth Continues - ...

    January 13, 2015
    Actavis (ACT) expects fourth quarter 2014 earnings to beat Wall Street consensus estimates; the Allergan acquisition is expected ...
  2. Actavis' Appeal Case for Namenda Gets Accelerated Hearing - ...

    January 7, 2015
    Actavis plc (ACT) confirmed that the U.S. Court of Appeals for the Second Circuit has granted the company's motion to expedite ...
  3. KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst ...

    January 7, 2015
    KaloBios Pharmaceuticals, Inc. (KBIO) announced that one of its principal candidates, KB001-A, has failed to meet the primary ...
  4. Another Delay for Salix Candidate - Analyst Blog

    September 10, 2012
    The US Food and Drug Administration (FDA) recently informed Salix Pharmaceuticals, Ltd. (SLXP) that it is still reviewing ...
  5. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
Trading Center